Hydrating softwood and hardwood samples using pure and modified supercritical carbon dioxide

This article describes an in-progress research project that looks to investigate the use of supercritical carbon dioxide (scCO2) for the addition of water to historic and modern, softwood and hardwood samples. The experiments were carried out at 20 MPa and 50 °C, the effects of co-solvent addition, methanol (MeOH), were examined. A three point bend test provided mechanical data for the wood samples treated with both pure and modified scCO2. All the wood samples, with only one exception, saw an increase in Modulus of Rupture (MOR) after being treated with scCO2. Thereby indicating an increased resistance to force in the treated samples. Diffuse Reflectance Infrared Fourier Transform (DRIFT) spectroscopy was performed to help deduce if any trends in the OH/CH and OH/Cellulose peak area ratios could be established with the nature of the treatment and the type of wood used. The development of this technique seeks to be relevant and safe for applications within modern conservation practices, where dry and fragile materials are prevalent

Lipid management in patients with chronic kidney disease.

An increased risk of cardiovascular disease, independent of conventional risk factors, is present even at minor levels of renal impairment and is highest in patients with end-stage renal disease (ESRD) requiring dialysis. Renal dysfunction changes the level, composition and quality of blood lipids in favour of a more atherogenic profile. Patients with advanced chronic kidney disease (CKD) or ESRD have a characteristic lipid pattern of hypertriglyceridaemia and low HDL cholesterol levels but normal LDL cholesterol levels. In the general population, a clear relationship exists between LDL cholesterol and major atherosclerotic events. However, in patients with ESRD, LDL cholesterol shows a negative association with these outcomes at below average LDL cholesterol levels and a flat or weakly positive association with mortality at higher LDL cholesterol levels. Overall, the available data suggest that lowering of LDL cholesterol is beneficial for prevention of major atherosclerotic events in patients with CKD and in kidney transplant recipients but is not beneficial in patients requiring dialysis. The 2013 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Lipid Management in CKD provides simple recommendations for the management of dyslipidaemia in patients with CKD and ESRD. However, emerging data and novel lipid-lowering therapies warrant some reappraisal of these recommendations